Skip to main content
Equibles

UBS Group AG

Position in NERV — Minerva Neurosciences, Inc.

CIK 1610520 ZURICH, V8
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$234,254
-$172,855 QoQ
Shares Held
42,208
-37.5% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 58 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. NERV ranks #331 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in NERV

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $234,254 42,208
2026-03-31 $407,109 67,570
2025-12-31 $7,263 1,807
2025-09-30 $21 10
2025-06-30 $1,504 875
2025-03-31 $2,755 1,621
2024-12-31 $26 12
2024-09-30 $28,173 10,552
2024-06-30 $31 10
2024-03-31 $25 10
2023-12-31 $399 65
2023-09-30 $365 53
2023-06-30 $3,966 434
2022-09-30 $52,906 5,732
2022-06-30 $1,870 565
2022-03-31 $14 17
2021-12-31 $13 17
2021-09-30 $29 17
2021-06-30 $21,640 9,328
2021-03-31 $75,957 26,013
2020-12-31 $54,727 23,388
2020-09-30 $2,922 919
2020-06-30 $34,760 9,629
2020-03-31 $263,049 43,696